Revisiting cardiovascular risk reduction in type 2 diabetes and dyslipidemia [0.03%]
2型糖尿病与血脂异常的心血管风险降低方案再思考
Phillip Lim,David Bleich
Phillip Lim
Statin therapy has been a mainstay of cardiovascular disease (CVD) risk reduction for the past 20 years in type 2 diabetes management. Its application has been largely due to well-designed, randomized-control studies consistently showing 25...
Blood lipid levels and treatment following an acute coronary syndrome or coronary intervention - Journey from hospital to cardiac rehabilitation [0.03%]
急性冠脉综合征或冠脉介入治疗后的血脂水平及其治疗措施——从住院到心脏康复的历程
David Rott,Ilan Hay,Irene Nabutovsky et al.
David Rott et al.
Background: A significant number of coronary artery disease patients do not attain guideline recommended LDL levels. Participating in a cardiac rehabilitation (CR) program has been shown to improve adherence to medical th...
Heterogeneity in the prevalence of premature hypertension among Asian American populations compared with white individuals: A National Health Interview Survey study [0.03%]
与白人相比，在亚裔美国人人群中早发性高血压患病率的异质性：一项全国健康访谈调查研究
Sina Kianoush,Mahmoud Al Rifai,Anwar T Merchant et al.
Sina Kianoush et al.
Background: Differences in prevalence of risk factors such as hypertension may explain heterogeneity in cardiovascular risk across Asian American populations. ...
Ranolazine - could an antianginal drug be used in stroke prevention? [0.03%]
Ranolazine——一种抗心绞痛药物或可用于预防卒中？
Stanisław Surma,Monika Romańczyk,Krzysztof J Filipiak
Stanisław Surma
Effectiveness of home-rehabilitation in patients after an acute coronary syndrome and myocardial revascularization [0.03%]
急性冠脉综合征和 myocardial revascularization 患者家庭康复的有效性
Marika Werren,Francesca Valent,Antonio Di Chiara
Marika Werren
Physical activity is a mainstay (class IA) of rehabilitation programme after an acute coronary syndrome, but less than 40% of patients is physically active at one year. Home-rehabilitation, initially designed to manage the increasing number...
Even chained acylcarnitines predict long-term cardiovascular prognosis in patients with chest pain and non-obstructive coronary artery disease [0.03%]
即使链酰基肉碱水平升高也预示着胸痛伴非阻塞性冠状动脉疾病患者的长期心血管结局
Silje Kjellevold Storesund,Iman Karaji,Elin Strand et al.
Silje Kjellevold Storesund et al.
Background: Acylcarnitines are essential for mitochondrial fatty acid oxidation. Earlier studies suggest that impaired energy metabolism may be implicated in the pathogenesis of microvascular angina. We explored metabolit...
Effects of moderate ethanol consumption as a function of n-6:n-3 dietary ratio on lipid profile, inflammation, and liver function in mice [0.03%]
中等量饮酒对小鼠血脂谱、炎症和肝功能的影响受n-6:n-3膳食比的影响
Kristine Giltvedt,Luciano S Voutour,Brianna Tursellino et al.
Kristine Giltvedt et al.
Objective: It is critical to understand how moderate ethanol exposure interacts with dietary components such as essential fatty acids to influence inflammatory processes underlying CVD pathogenesis. The purpose of this st...
Presence of asymptomatic Peripheral Arterial Disease in combination with common risk factors elevates the cardiovascular risk Substantially [0.03%]
无症状外周动脉疾病合并常见心血管危险因素显著增加心血管病事件风险
Fredrik Sartipy,Antonio José Garcia Pereira Filho,Fredrik Lundin et al.
Fredrik Sartipy et al.
Background and aims: This study evaluates the risks for adverse cardiovascular (CV) events in Asymptomatic Peripheral Arterial Disease (APAD) combined with different traditional CV risk factors. ...
Assessment of one-year risk of ischemic stroke versus major bleeding in patients with atrial fibrillation [0.03%]
房颤患者缺血性卒中与出血的一年风险评估
Davit Sargsyan,Javier Cabrera,Yajie Duan et al.
Davit Sargsyan et al.
Background: Patients diagnosed with atrial fibrillation (AF) are at increased risk of stroke. Several guidelines to assess the risk of ischemic stroke and major bleeding in AF patients have been published. The CHA 2 DS 2 ...
Risk factor control among heart failure patients in the United States: Results from the NHANES 1999-2018 [0.03%]
1999～2018年美国国家健康与营养调查（NHANES）中心脏病患者的危险因素控制情况
Ying Tang,Jing Yan,Lijiang Tang et al.
Ying Tang et al.
Background: Compliance with recommended pharmacological and non-pharmacological treatments to modify risk factors is associated with improved outcomes for patients with heart failure (HF). ...